A phase 1 trial of recombinant human IL-21 in combination with cetuximab in patients with metastatic colorectal cancer.

Br J Cancer · 2012 · PMC3305963 · PMID 22315057

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

A clear drop in T-helper cells (CD45+/CD3+/CD4+, 403 vs 310 cells μ l −1 , P =0.0876) were also observed, but this did not reach statistical significance.

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.